recombinant dna technology in medicine...recombinant dna technology in medicine 50 years of...

40
RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty of Pharmacy, Ljubljana

Upload: others

Post on 27-Jul-2020

59 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

RECOMBINANT DNA TECHNOLOGY IN MEDICINE50 years of recombinant drugs

Asist. Dr. Matjaž Ravnikar, M Pharm

Chair of Pharmaceutical Biology

Faculty of Pharmacy, Ljubljana

Page 2: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

RECOMBINANT DNA TECHNOLOGY

BIOTECHNOLOGY

RECOMBINANT DNA

TECHNOLOGY

Page 3: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

RECOMBINANT DNA TECHNOLOGY

Recombinant DNA (rDNA) technology refers to the process of joining DNA molecules from two different sources and inserting them into a host organism, to generate products for human use.

Page 4: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

APPLICATIONS OF RECOMBINANT DNA TECHNOLOGY

Therapeutic products

Vaccines

Recombinant proteins

Vectors

Growth hormones

Anticancer drugs

Genetically modified products

GM vegetables

GM crops

GM microbes

GM animals

Diagnosis

Gene therapy

CRISPR

Monitoring devices

Therapeutic strategies

Energy applications

Biohydrogen

Bioethanol

Biomethanol

Biobutanol

Recombinant DNA Technology

Page 5: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

SMALL MOLECULES AND PROTEINS

Discovered by chance Very similar to proteins in the body

Page 6: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

DIABETES (Type 1)

Page 7: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

History of Diabetes treatment

-Until 1920s deadly disease with no cure

-Porcine and bovine insulin (allergic reactions)

-2 tones of pig pancreatic tissue for 250 ml of Insulin

-Recombinant (human) insulin (1980s)

Page 8: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Advencements in Insulin therapy

Page 9: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

From Gene to Protein

Page 10: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Polymerase chain reaction

Page 11: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Polymerase chain reaction

-Kary Mullis 1983

-thermo-stabile polymerase

https://www.youtube.com/watch?v=iQsu3Kz9NYo

Page 12: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Principles of drug discovery

Receptors & ligands!

Page 13: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Cell communication & phisiological responce

Page 14: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Agonists and antagonists

Page 15: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

PROCESS OF RECOMBINANT DRUG PRODUCTION

Page 16: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Searching for new drug candidates

Page 17: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Peptide candidates screening

- Phage Display

- Bacteriophages

- Libraries of peptides

- Up to 1012 combinations

- Sequencing of positive clones

Page 18: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Development of recombinant cell line

Page 19: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Expression and purification of recombinantprotein

Page 20: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

RECOMBINANT MOLECULES IN CLINICAL USE

-Enzymes and regulatory proteins

(Human growth hormone, Insulin,…)

-Antibodies

(Cancer therapy)

-Vaccines

(HPV virus)

-Proteins for diagnostics

(affinity molecules)

-Gene therapy

(nucleic acids, recombinant vectors)

Page 21: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Pros and Cons of recombinant proteins

Pros:

-high efficiency

-homology to endogenous proteins in our body

-few side effects

-new therapy options

Cons:

-expensive to produce

-protein structure usually requires parenteral application

-extensive purification, sterility required

-systemic effect

Page 22: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

ANTIBODIES

Page 23: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Types of monoclonal antibodies

Page 24: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Antibodies targeting cancer cells

Page 25: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Varieties of antibody fragments

Page 26: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Recombinant vaccines

Page 27: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

DNA vaccines

Page 28: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

FUSION PROTEINS

-Chemical fusion

-Recombinant fusion

Page 29: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Fusion proteins advantages

- Easier cleaning (affinity tags)

- Directed expression (signaling peptide, extracellular)

- Visualization (fluorescent peptides)

- Enhancing cathalytic activity

- Enhancing stability

- Enhancing solubility

- Improving expression levels

- …

Page 30: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Example: design and preparation ofrecombinant probiotic

Page 31: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

GENE THERAPY(fixing genetic problem at its source)

Cancer therapies

Page 32: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

In-vivo and Ex-vivo gene transfer

Page 33: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

First trials

-Adenosine deaminase deficiency leads to immunodeficiency

("Bubble kids")

Danger of developing leukemia (insertional mutagenesys)!

Page 34: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Drawbacks of early gene therapies

-can damage vital genes

-can trigger lethal immune response to viral carrier

However…

-In therapy: Zolgensma® (1.8MEur) - Spinal muscular atrophy (AAV)

Page 35: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

"Zinc finger" nucleases

Artificial nucleases, capable of recognizing specific DNA sequences

Page 36: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

TALENs (Transcription Activator-Like Effector Nucleases)

-tandem repeats of 34 amino acids, containing 2 variable AA

Page 37: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

CRISPR CAS

https://www.youtube.com/watch?v=2pp17E4E-O8

Page 38: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Future of recombinant DNA technology in medicine and ethical concerns

- Reproductive cloning: mice, cattle, pigs, goats, rabbits, and cats

- From repairing to enhancing human performance?

Page 39: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty

Thank you for your attention!

Page 40: RECOMBINANT DNA TECHNOLOGY IN MEDICINE...RECOMBINANT DNA TECHNOLOGY IN MEDICINE 50 years of recombinant drugs Asist. Dr. Matjaž Ravnikar, M Pharm Chair of Pharmaceutical Biology Faculty